{"Abstract": [0], "Infection": [1], "susceptibility,": [2], "poor": [3], "vaccination": [4], "efficacy,": [5], "age-related": [6, 63, 205], "disease": [7], "onset,": [8], "and": [9, 15, 54, 73, 84, 94, 124, 144, 190, 203], "neoplasms": [10], "are": [11, 76], "linked": [12, 51], "to": [13, 29, 52, 113, 147, 195], "innate": [14], "adaptive": [16], "immune": [17, 92, 96], "dysfunction": [18], "that": [19, 35, 104, 120], "accompanies": [20], "aging": [21], "(known": [22], "as": [23], "immunosenescence).": [24], "During": [25], "aging,": [26], "organisms": [27], "tend": [28], "develop": [30, 98], "a": [31, 48, 99, 165], "characteristic": [32], "inflammatory": [33], "state": [34], "expresses": [36], "high": [37], "levels": [38], "of": [39, 79, 91, 141, 167, 171, 176, 199], "pro-inflammatory": [40], "markers,": [41], "termed": [42], "inflammaging.": [43, 106], "This": [44], "chronic": [45, 85], "inflammation": [46], "is": [47, 56, 117, 181, 193], "typical": [49], "phenomenon": [50], "immunosenescence": [53, 153, 177, 200], "it": [55, 116, 192], "considered": [57], "the": [58, 108, 168, 174, 197], "major": [59, 128], "risk": [60], "factor": [61], "for": [62, 158], "diseases.": [64, 206], "Thymic": [65], "involution,": [66], "na\u00efve/memory": [67], "cell": [68], "ratio": [69], "imbalance,": [70], "dysregulated": [71], "metabolism,": [72], "epigenetic": [74], "alterations": [75], "striking": [77], "features": [78], "immunosenescence.": [80, 132, 149], "Disturbed": [81], "T-cell": [82], "pools": [83], "antigen": [86], "stimulation": [87], "mediate": [88], "premature": [89], "senescence": [90, 143], "cells,": [93], "senescent": [95, 121], "cells": [97, 123], "proinflammatory": [100], "senescence-associated": [101], "secretory": [102], "phenotype": [103], "exacerbates": [105], "Although": [107], "underlying": [109], "molecular": [110], "mechanisms": [111], "remain": [112], "be": [114, 127, 137], "addressed,": [115], "well": [118], "documented": [119], "T": [122], "inflammaging": [125], "might": [126], "driving": [129], "forces": [130], "in": [131, 161, 201], "Potential": [133], "counteractive": [134], "measures": [135], "will": [136], "discussed,": [138], "including": [139], "intervention": [140], "cellular": [142], "metabolic-epigenetic": [145], "axes": [146], "mitigate": [148], "In": [150], "recent": [151], "years,": [152], "has": [154], "attracted": [155], "increasing": [156], "attention": [157], "its": [159], "role": [160, 198], "tumor": [162], "development.": [163], "As": [164], "result": [166], "limited": [169], "participation": [170], "elderly": [172], "patients,": [173], "impact": [175], "on": [178], "cancer": [179, 202], "immunotherapy": [180], "unclear.": [182], "Despite": [183], "some": [184], "surprising": [185], "results": [186], "from": [187], "clinical": [188], "trials": [189], "drugs,": [191], "necessary": [194], "investigate": [196], "other": [204]}